BioSante Pharmaceuticals, Inc. (BPAX) Reports First Quarter Financial Results  
5/13/2013 7:12:16 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today reported on its cash balance as of March 31, 2013 and financial results for the quarter ended March 31, 2013.

As of March 31, 2013, the Company’s cash and cash equivalents were approximately $29.4 million and convertible notes payable on May 1, 2013 were approximately $8.2 million. Subsequent to the end of the quarter and prior to the May 1, 2013 maturity date of the notes, the Company repaid the outstanding principal amount of the notes, plus all accrued and unpaid interest thereon.

Help employers find you! Check out all the jobs and post your resume.